Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Solutions To The Challenges Of Oncology Trials
This significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.
Stop Guessing On Trial Feasibility: Simulating Patient Recruitment With AI
Simulate enrollment, endpoints, and criteria with integrated data and synthetic populations to test protocol feasibility early — refining design and reducing recruitment and regulatory risks.
A 2025 Survey Report Uncovers The Top 5 Clinical Trial Cost Insights
In this 2025 survey of over 100 U.S. clinical trial participants and caregivers, we reveal that most individuals join trials seeking life-saving treatment, not financial gain.
Insights From The EACT Clinical Trials Site Personnel Webinar
Collaboration among clinical research stakeholders is breaking financial barriers to support equitable trial access.

Biotech Landscape Continues To Shift
9/18/2025

Global shifts are adding new layers of challenge and opportunity for the biotech sector, as companies navigate a period of unprecedented complexity.
CRF Validation Best Practices: Building Reliable Clinical Trial Databases
6/29/2026

CRF validation improves data quality and efficiency. Early planning, clear edit checks, and balance reduce rework, ease site burden, and enable more reliable, streamlined study execution.
Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, And Proven Strategies
8/29/2025

Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.
Streamlining Phase 1 Trials With The Mobile Vision Pod
1/29/2025

A contract research organization formed a partnership to address significant challenges during a Phase 1 clinical trial for a corneal disease treatment through the use of a Mobile Vision Pod.
Meeting Regulatory And Patient Needs By Improving Clinical Trial Access
3/26/2026

Learn how to mitigate regulatory risk and improve trial diversity by reducing site burden and leveraging integrated technology to reach U.S. patients in their own communities.

Enhance Clinical Trial Screening And Improve Patient Matching Accuracy

Bridge the gap between raw data and clinical enrollment. Use AI-driven insights and natural language summaries to identify the right patients faster and with greater transparency.
De-Risk Randomization With The Endpoint Biostatistical Approach

With over 15 years of RTSM experience, high-touch quality management, and forward-thinking technology, our solutions enhance trial speed, accuracy, and operational efficiency.
Bold Thinking Overcomes Oncology Clinical Development Challenges

Veristat ensures that your clinical trial or program design supports your regulatory strategy, whether you plan to run a single pivotal trial or multiple trials.
Truth At The Source - Visibility In Real Time

Clinical trial execution, live.

Live Data Capture™, protocol-guided workflows, and source-level visibility for site & sponsor teams.
Your Top Partner For Ophthalmic Drug Development

As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.